City, University of London Featured PhD Programmes
University of Sheffield Featured PhD Programmes
Engineering and Physical Sciences Research Council Featured PhD Programmes
FindA University Ltd Featured PhD Programmes
FindA University Ltd Featured PhD Programmes

Influencing the chemistry and biochemistry of electron-deficient organometallics

This project is no longer listed on FindAPhD.com and may not be available.

Click here to search FindAPhD.com for PhD studentship opportunities
  • Full or part time
    Dr Nicolas Barry
    Dr William Martin
    Dr Steven Shnyder
  • Application Deadline
    No more applications being accepted
  • Funded PhD Project (European/UK Students Only)
    Funded PhD Project (European/UK Students Only)

Project Description

In 2012, 14 million new cases of cancer were diagnosed worldwide, while 8.2 million people died due to cancer or related illnesses. In 2015, the number of cancer related deaths increased to 8.8 million people and it is expected to increase to 23.6 million by 2030. Many efforts have been focused on the development of chemotherapeutics (drugs) capable of fighting cancers. However, drug resistance and toxicity (due to lack of selectivity) are major drawbacks of chemotherapy. New anti-cancer drugs which are more selective, less toxic and with new mechanisms of action are therefore urgently needed.

Conventional anti-cancer drugs are mostly organic molecules, but structures where inorganic metals are incorporated in the form of metal coordination complexes offer potentially unique biological and chemical diversity which are quite distinct from that of the more conventional organic drugs. This arises not only from the choice of the metal itself and its oxidation state, but also from the types and numbers of coordinated ligands and the coordination geometry of the complex. We have recently developed a particular type of coordination complexes, so called electron-deficient half-sandwich complexes, which possess remarkably high cytotoxicity and selectivity towards a range of cancer cell lines (colon, ovarian, lung). One complex in particular was found to be 70 x more potent than the clinically used cisplatin drug against ovarian cancer cells, whilst exhibiting an in vitro >50 x selectivity against normal cells. Their outstanding capabilities to preferentially kill cancer cells over normal cells stem from the oxidative stress which those compounds induce in cancer cells (related to the unusual redox activity of these complexes).

In this research programme, the doctoral candidate will undertake a thorough investigation of the structure–activity relationship of such compounds. A variety of organic ligands will be synthesised and coordinated to the metal ions in order to tune the biological activity of the resulting complexes. In vitro screening will be carried out by the doctoral candidate and the biological results will inform the chemical design. The subsequent elucidation of the metallodrug mechanism of action will inform further molecule synthesis and design. As such, this proposal includes elements of underpinning concept which will ultimately lead to the identification of novel metal-based lead molecules that will be strong candidates for pre-clinical research.

Funding Notes

This is a full time funded studentship awarded by the University of Bradford providing a full Stipend (2019/20 £15,009) and UK/EU fees for 1st October 2019 start.



FindAPhD. Copyright 2005-2019
All rights reserved.